Li Z et al. also reported that activation of SMAD2/3 can effectively inhibit the expression of NLRP3, reducing the pyroptosis of hypoxic cardiomyocytes [19], whether SMAD2 participates in the pyroptosis of FLS-RA during RA has not been cleared. Here, NLRP3 is linked to rheumatoid arthritis.